Private Ocean’s Regeneron Pharmaceuticals REGN Stock Holding History

Private Ocean’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$2.1K	Buy	+2	New	+$1.94K	﹤0.01%	522
2021 Q3	–	Sell	-22	Closed	-$12K	–	617
2021 Q2	$12K	Sell	22 -5	-19%	-$2.53K	﹤0.01%	391
2021 Q1	$13K	Hold	27	–	–	﹤0.01%	410
2020 Q4	$13K	Buy	27 +5	+23%	+$2.7K	﹤0.01%	359
2020 Q3	$12K	Hold	22	–	–	﹤0.01%	362
2020 Q2	$13K	Hold	22	–	–	﹤0.01%	338
2020 Q1	$10K	Buy	+22	New	+$9.07K	﹤0.01%	389
2018 Q1	–	Sell	-5	Closed	-$2K	–	498
2017 Q4	$2K	Buy	+5	New	+$2.02K	﹤0.01%	368

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Private Ocean's REGN Position: Q2 2024 in Review

Private Ocean opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2024: 2 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #522 among its holdings. This is a return to the name: Private Ocean previously reported a position in REGN as recently as Q2 2021.

Private Ocean first reported a position in REGN in Q4 2017 and has held it in 8 quarters since. The position peaked at $13K in Q1 2021. 1,331 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

Private Ocean held 2 shares of Regeneron Pharmaceuticals worth $2.1K as of Q2 2024.
Regeneron Pharmaceuticals was a new Private Ocean position in Q2 2024.
Regeneron Pharmaceuticals made up ﹤0.01% of Private Ocean's portfolio in Q2 2024, its #522 holding.
Private Ocean first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 8 quarters since.
Private Ocean's Regeneron Pharmaceuticals position peaked at $13K in Q1 2021.
1,331 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on Private Ocean's 13F filing for Q2 2024, filed 30 Jul 2024.